Clinical Trials Directory

Trials / Completed

CompletedNCT01792817

Non-invasive Neurostimulation of the Vagus Nerve for the Treatment of Cluster Headache

Non-invasive Neurostimulation of the Vagus Nerve With the GammaCore Device for the Treatment of Cluster Headache

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
150 (actual)
Sponsor
ElectroCore INC · Industry
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Multi-center, prospective, double-blind, randomized, sham-controlled pivotal study of non-invasive vagus nerve stimulation with the GammaCore® device for the acute treatment of cluster headache. The study compares the safety and effectiveness of an active treatment (GammaCore) against a sham treatment.

Detailed description

Phase 1: Prospective, randomized (1:1 active treatment:sham control allocation), double blinded, sham controlled treatment (active or sham) phase Phase 2: Prospective, non-randomized, active treatment phase. Phase 1 - Two Arms: 1. Active Treatment with the GammaCore Device 2. Sham Treatment with a placebo device Phase 2 - One Arm: Active Treatment with the GammaCore Device

Conditions

Interventions

TypeNameDescription
DEVICEGammaCoreTreatment with active gammacore vagus nerve stimulator
DEVICESham GammaCore deviceTreatment with sham stimulator

Timeline

Start date
2013-02-01
Primary completion
2014-06-01
Completion
2014-10-01
First posted
2013-02-15
Last updated
2019-12-17
Results posted
2018-05-17

Locations

20 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01792817. Inclusion in this directory is not an endorsement.